Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial

BACKGROUND: Pneumocystis pneumonia (PCP) is a common acquired immune deficiency syndrome (AIDS)-related opportunistic infection. Recent reports estimate that more than 400,000 patients with human immunodeficiency virus (HIV) develop PCP each year globally. However, the timing of antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yuanyuan, Lu, Yanqiu, Zhou, Yihong, Harypursat, Vijay, Sun, Feng, Yang, Sen, Tang, Shengquan, Li, Yao, He, Xiaoqing, Zeng, Yanming, Chen, Yaokai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310256/
https://www.ncbi.nlm.nih.gov/pubmed/32571429
http://dx.doi.org/10.1186/s13063-020-04450-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310256/
https://www.ncbi.nlm.nih.gov/pubmed/32571429
http://dx.doi.org/10.1186/s13063-020-04450-8

Ejemplares similares